Description: Vetmedin®–CA1 is indicated for the delay onset of congestive heart failure in dogs with stage B2 preclinical myxomatous mitral valve disease (MMVD). This medication is for dogs in pre–clinical stage B2 (asymptomatic MMVD with a moderate or loud mitral murmur due to mitral regurgitation and evidence of increased heart size) to delay the onset of clinical signs of heart failure.
Product: Vetmedin®–CA1 Chewable Tablets
For: Dogs
Generic Name: Pimobendan
Brand Name: Vetmedin®–CA1
Drug Class: Inodilator
Manufacturer: Boehringer Ingelheim
Product Description & Form: Vetmedin®–CA1 1.25 mg Chewable Tablets: 16 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010–4610–01) Vetmedin®–CA1 1.25 mg Chewable Tablets Vetmedin®–CA1 5 mg Chewable Tablets: 23 mm, brown, oval tablet, scored in half, no imprint. (NDC 00010–4612–01)Vetmedin®–CA1 5 mg Chewable Tablets
Benefits:
Indicated for the delay onset of congestive heart failure in dogs with stage B2 preclinical myxomatous mitral valve disease (MMVD) For dogs in pre–clinical stage B2 (asymptomatic MMVD with a moderate or loud mitral murmur due to mitral regurgitation and evidence of increased heart size) to delay the onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141–556.